PH12019500377A1 - Composition comprising multivalent capsular polysaccharide-transport protein and use thereof - Google Patents

Composition comprising multivalent capsular polysaccharide-transport protein and use thereof

Info

Publication number
PH12019500377A1
PH12019500377A1 PH12019500377A PH12019500377A PH12019500377A1 PH 12019500377 A1 PH12019500377 A1 PH 12019500377A1 PH 12019500377 A PH12019500377 A PH 12019500377A PH 12019500377 A PH12019500377 A PH 12019500377A PH 12019500377 A1 PH12019500377 A1 PH 12019500377A1
Authority
PH
Philippines
Prior art keywords
composition
capsular polysaccharide
transport protein
multivalent
multivalent capsular
Prior art date
Application number
PH12019500377A
Other languages
English (en)
Inventor
Tae Hyun Kim
Hoon Sung Jeh
Original Assignee
Lg Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd
Publication of PH12019500377A1 publication Critical patent/PH12019500377A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55516Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
PH12019500377A 2016-09-06 2019-02-21 Composition comprising multivalent capsular polysaccharide-transport protein and use thereof PH12019500377A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160114591 2016-09-06
PCT/KR2017/009569 WO2018048141A1 (ko) 2016-09-06 2017-08-31 다가 협막 다당류-운반 단백질을 포함하는 조성물 및 이의 용도

Publications (1)

Publication Number Publication Date
PH12019500377A1 true PH12019500377A1 (en) 2019-10-21

Family

ID=61561397

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12019500377A PH12019500377A1 (en) 2016-09-06 2019-02-21 Composition comprising multivalent capsular polysaccharide-transport protein and use thereof

Country Status (12)

Country Link
KR (1) KR101991457B1 (ar)
BR (1) BR112019004303A2 (ar)
EA (1) EA201990451A1 (ar)
JO (1) JOP20190038B1 (ar)
MA (1) MA45283B1 (ar)
MX (1) MX2019002552A (ar)
MY (1) MY192792A (ar)
PH (1) PH12019500377A1 (ar)
SA (1) SA519401232B1 (ar)
TN (1) TN2019000064A1 (ar)
WO (1) WO2018048141A1 (ar)
ZA (1) ZA201901969B (ar)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7369123B2 (ja) 2017-12-06 2023-10-25 メルク・シャープ・アンド・ドーム・エルエルシー 肺炎球菌多糖類-タンパク質コンジュゲートを含む組成物およびその使用方法
US11123417B2 (en) 2018-02-05 2021-09-21 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
AU2019256218A1 (en) * 2018-04-18 2020-12-03 Sk Bioscience Co., Ltd. Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof
MA54533A (fr) 2018-12-19 2022-03-30 Merck Sharp & Dohme Compositions comprenant des conjugués polysaccharide-protéine de streptococcus pneumoniae et leurs méthodes d'utilisation
WO2023218322A1 (en) * 2022-05-11 2023-11-16 Pfizer Inc. Process for producing of vaccine formulations with preservatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE254475T1 (de) * 1993-09-22 2003-12-15 Jackson H M Found Military Med Verfahren zur aktivierung von löslichem kohlenhydraten durch verwendung von neuen cyanylierungsreagenzien, zur herstellung von immunogenischen konstrukten
CN102716480B (zh) * 2005-04-08 2023-03-21 惠氏有限责任公司 多价肺炎球菌多糖-蛋白质缀合物组合物
SI3170508T1 (sl) * 2010-06-04 2020-01-31 Wyeth Llc Formulacije cepiva
KR102057217B1 (ko) * 2012-06-20 2020-01-22 에스케이바이오사이언스 주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
CN103893751B (zh) * 2014-03-26 2016-04-20 天津康希诺生物技术有限公司 一种肺炎球菌多糖蛋白缀合疫苗及其制备方法
CN104069504B (zh) * 2014-05-11 2019-09-24 江苏康泰生物医学技术有限公司 一种增强多糖蛋白结合物免疫原性的方法

Also Published As

Publication number Publication date
KR101991457B1 (ko) 2019-09-30
JOP20190038B1 (ar) 2023-09-17
EA201990451A1 (ru) 2019-08-30
MA45283A1 (fr) 2019-06-28
KR20180027353A (ko) 2018-03-14
WO2018048141A1 (ko) 2018-03-15
ZA201901969B (en) 2019-12-18
BR112019004303A2 (pt) 2019-05-28
JOP20190038A1 (ar) 2019-03-06
MX2019002552A (es) 2019-07-01
TN2019000064A1 (en) 2020-07-15
SA519401232B1 (ar) 2022-10-23
MY192792A (en) 2022-09-09
MA45283B1 (fr) 2021-05-31

Similar Documents

Publication Publication Date Title
PH12021550318A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
PH12019500377A1 (en) Composition comprising multivalent capsular polysaccharide-transport protein and use thereof
IL297575B1 (en) Multivalent vaccines for lung spot that include polysaccharide-protein conjugates
MX2022014850A (es) Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
MX2022009928A (es) Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
BR112016015835A2 (pt) Polissacarídeos capsulares de streptococcus pneumoniae e conjugados destes
MX2017009308A (es) Composiciones inmunogenicas para usar en vacunas neumococicas.
PH12018500037A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
MX2022009927A (es) Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
MX2019008564A (es) Composiciones inmunogenicas para su uso en vacunas neumococicas.
MX2020002555A (es) Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
EP3863667A4 (en) POLYVALENT PNEUMOCOCCAL POLYSACCHARIDE PROTEIN CONJUGATE VACCINE
PH12018501205A1 (en) Synthetic vaccines against streptococcus pneumoniae serotype 2
MX2016000099A (es) Vacunas sinteticas contra streptococcus pneumoniae tipo 1.
SG11201911757WA (en) Novel multivalent polysaccharide - protein conjugate vaccine composition and formulation thereof
WO2016198170A8 (en) Vaccines against streptococcus pneumoniae serotype 5
MX2017016858A (es) Composiciones inmunogenicas.